Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity

v3.22.1
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at the beginning at Dec. 31, 2020 $ 118 $ 40,770,504 $ (16,289,077) $ 24,481,545
Balance at the beginning (in shares) at Dec. 31, 2020 11,756,109      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation: Common stock $ 1 513,102   513,103
Stock-based compensation: Common stock (in shares) 70,040      
Stock-based compensation: Options   2,576   2,576
Shares issued upon exercise of warrants, net of issuance costs [1] $ 20 9,274,891   9,274,911
Shares issued upon exercise of warrants, net of issuance costs (in shares) [1] 2,047,361      
Net loss     (1,796,612) (1,796,612)
Balance at the end at Mar. 31, 2021 $ 139 50,561,073 (18,085,689) 32,475,523
Balance at the end (in shares) at Mar. 31, 2021 13,873,510      
Balance at the beginning at Dec. 31, 2021 $ 143 52,030,907 (26,580,790) 25,450,260
Balance at the beginning (in shares) at Dec. 31, 2021 14,253,948      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Surrender and cancellation of common stock   (18,683)   (18,683)
Surrender and cancellation of common stock (in shares) (3,397)      
Stock-based compensation: Common stock   430,361   430,361
Stock-based compensation: Common stock (in shares) 53,192      
Stock-based compensation: Options   2,295   2,295
Net loss     (3,627,492) (3,627,492)
Balance at the end at Mar. 31, 2022 $ 143 $ 52,444,880 $ (30,208,282) $ 22,236,741
Balance at the end (in shares) at Mar. 31, 2022 14,303,743      
[1] Includes gross proceeds of $9,708,038, less issuance costs of $433,127.